Surfactant treatment of the very preterm infant

Biology of the Neonate

Volumn 74, Issue SUPPL. 1, 1998, Pages 35-42

  Soll, Roger F ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; SURFACTANT;

CLINICAL TRIAL; CONFERENCE PAPER; FETUS LUNG MATURATION; HUMAN; META ANALYSIS; NEWBORN; PREMATURITY; PRIORITY JOURNAL; SURVIVAL; VERY LOW BIRTH WEIGHT;

ANIMALS; DISEASE MODELS, ANIMAL; FETAL ORGAN MATURITY; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS;

EID: 0031689410     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047033     Document Type: Conference Paper

References (22)

1. Lorenze JM, Wooliever DE, Jetton JR, Paneth N: A quantitative review of mortality and developmental disability in extremely premature newborns. Arch Pediatr Adolesc Med 1998;152:425-435.
2. Horbar JD, Wright EC, Onstad L, members of the NICHHD Neonatal Research Network: Decreasing mortality associated with the introduction of surfactant therapy: An observational study of neonates weighing 601-1300 grams at birth. Pediatrics 1993;92:191-196.
3. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ: Effect of surfactant on morbidity, mortality and resource use in newborn infants weighing 500-1500 gms. N Engl J Med 1994;330:1476-1480.
4. Walther FJ, Blanco CE, Houdijk M, Bevers EM: Single versus repetitive doses of natural surfactant as treatment of respiratory distress syndrome in premature lambs. Pediatr Res 1985;19:224-227.
5. Soll RF, McQueen MC: Respiratory distress syndrome; in Sinclair JC, Bracken MB (eds): Effective Care of the Newborn. Oxford, Oxford University Press, 1992, pp 325-358.
6. Stevenson D, Walther F, Long W, Sell M, Pauly T, Gong A, Easa D, Pramanik A, LeBlanc M, Anday E: Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I. J Pediatr 1992; 120(suppl):3-12.
7. Walther FJ, Mullett M, Schumacher R, Sundell H, Easa D, Long W: One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: Results of a double-blind trial. American Exosurf Neonatal Study Group I. J Pediatr 1995;126(suppl): 13-19.
8. Smyth J, Allen A, MacMurray B, Peliowski A, Sankaran K, Volbert F, Shukla A, Long W, Canadian Exosurf Neonatal Study Group: Double-blind, randomized, placebo controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500-749 grams with respiratory distress syndrome. J Pediatr 1995;126: 581-589.
9. Casiro O, Bingham W, MacMurray B, Whitfield M, Saigal S, Vincer M, Long W: One year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. J Pediatr 1995;126:553-560.
10. Hoekstra RE, Jackson JC, Myers TF, Frantz ID 3rd, Stern ME, Powers WF, Maurer M, Raye JR, Carrier ST, Gunkel JH: Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 1991;88:10-18.
11. Liechty EA, Donovan E, Purohit D, Gilhooly J, Feldman B, Noguchi A, Denson SE, Sehgal SS, Gross I, Stevens D: Reduction of neonatal mortality after multiple doses of bovine surfactant in low birthweight neonates with respiratory distress syndrome. Pediatrics 1991;88:19-28.
12. Hoekstra RE, Ferrara TB, Payne NR: Effects of surfactant therapy on outcome of extremely premature infants. Eur J Paediatr 1994; 153(suppl 2):12-16.
13. Vermont Oxford Network. Annual Reports.
14. Costeloe K, for EPICure Study Group: EPICure: Survival and morbidity of extremely preterm infants at discharge from hospital (abstract). Pediatr Res 1998;43:211.
15. Soll RF, Morley CJ: Prophylactic surfactant vs. treatment with surfactant (Cochrane Review): in: The Cochrane Library, Issue 2. Oxford, Update Software, 1998, updated quarterly.
16. Kendig JW, Notter RH, Cox C, Reubens LJ, Davis JM, Maniscalco WM, Sinkin RA, Bartoletti A, Dweck HS, Horgan MJ: A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med 1991;324:865-871.
17. Spafford PS, Kendig JW, Maniscalco WM: Use of natural surfactants to prevent and treat respiratory distress syndrome. Semin Perinatol 1993;17:285-294.
18. Horbar JD, Wright LL, Soll RF, Wright EC, Fanaroff AA, Korones SB, Shankaran S, Oh W, Fletcher BD, Bauer CR, Tyson JE, Lemon SJA, Donovan EF, Stoll BJ, Stevenson DD, Papile L-A, Phillips J III, for the NICHHD Neonatal Research Network: A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993;123:757-766.
19. Vermont Oxford Neonatal Network: A multicenter randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 1996;97:1-6.
20. Ikegami M, Jobe AH, Seidner S, Yamada T: Gestational effects of corticosteroids and surfactant in ventilated rabbits. Pediatr Res 1989;25: 32-37.
21. Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, Ikonen RS: Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: A randomized placebo-controlled multicenter study. Pediatrics 1994; 93.730-736.
22. Jobe AH: Pulmonary surfactant therapy. N Engl J Med 1993;328: 861-868.